Filter by tags: Research reactor French Alternative Energies and Atomic Energy Commission Clear all tag filters
3 news articles found
Pilot facility to be set up at new Framatome laboratory in France
The FRM II research neutron source at TUM in Garching, north of Munich. Photo courtesy TUM.
An agreement between the Technical University of Munich (TUM) and French fuel element manufacturer Framatome could lead to a joint pilot project to manufacture a monolithic uranium molybdenum alloy (UMo) fuel that could be in production by 2022.
TUM said the contract, announced by Framatome earlier this week, includes the development of a pilot production line and the production of fuel plates for radiation tests. These tests are a central part of the qualification of the new fuel, especially for research reactors in Europe, TUM said.
The pilot production facility will be set up at Framatome’s new research and development laboratory, in Romans-sur-Isère in southeastern France.
TUM said the contract, announced by Framatome earlier this week, includes the development of a pilot production line and the production of fuel plates for radiation tests. These tests are a central part of the qualification of the new fuel, especially for research reactors in Europe, TUM said.
The pilot production facility will be set up at Framatome’s new research and development laboratory, in Romans-sur-Isère in southeastern France.
TUM said the first prototype fuel elements are expected to be manufactured in early 2021. If the tests are successful, production could start as early as 2022.
- Source: Nucnet
- Date: Friday, 08 May 2020
- Original article: nucnet.org/news/agreement-could-lead-to-production-in-2022-says-tum-5-4-2020
French nuclear company Framatome and the Technical University of Munich have begun the commercial development of uranium-molybdenum fuel (UMo) for nuclear research reactors.
Framatome and TUM will design and install a fuel manufacturing production line, and develop, produce and irradiate new fuel prototypes.
The project will take place at the Cerca Research and Innovation Lab (CRIL), Framatome’s new research and development laboratory for the fabrication of nuclear fuels for medical, research and sterilisation applications.
Framatome and TUM will design and install a fuel manufacturing production line, and develop, produce and irradiate new fuel prototypes.
The project will take place at the Cerca Research and Innovation Lab (CRIL), Framatome’s new research and development laboratory for the fabrication of nuclear fuels for medical, research and sterilisation applications.
UMo fuel has a higher level of uranium density than uranium-silicon fuel, so it can use LEU instead of HEU. The fuel can also improve the performance of research reactors, according to Framatome.
- Source: Nucnet
- Date: Wednesday, 06 May 2020
- Original article: nucnet.org/news/framatome-and-tum-begin-commercial-development-5-2-2020
France's Framatome and the Technical University of Munich (TUM) in Germany have started commercial development of nuclear research reactor fuels based on uranium-molybdenum fuel (U-Mo) alloys. The fuel can be used instead of highly enriched uranium (HEU), which is seen as a potential nuclear proliferation risk.
- Source: World Nuclear News
- Date: Wednesday, 06 May 2020
- Original article: world-nuclear-news.org/Articles/Framatome-TUM-to-develop-new-research-reactor-fuel